Elevating Valve Service with Thorough Data and Scheduling

In the wake of the COVID-19 pandemic, water management facilities have had to figure out how to keep systems up and running while avoiding putting their technicians and other employees at risk of contracting or spreading the coronavirus.

Simply not servicing valves is not an option. A malfunction can lead to a serious headache, said Roger Lah, Technical Product Specialist for Cla-Val, not only in terms of coping with a malfunction but also from bad press or frustrated residents.

“Whenever you see a pipe main failure on the nightly news, they don’t talk about how it happened. It could be just old pipes, or it could’ve been a valve that was never serviced that actually caused the problem to begin with,” Lah said. “There’s often a story behind it.”

Fortunately for managers, a Cla-Val valve and Link2Valves, “a simple to use tool that manages the service scheduling of automatic control valves and other water system assets,” may be the perfect solution, said Mike Trosper, Western Region Service Manager.

“A lot of these valves are installed in vaults and stuff, so it’s confined space, and it takes a crew of two or three guys. With the electronic monitoring, you don’t need anything,” Trosper said. “You’ve got three guys you don’t need to put in a truck together or keep them all separated and don’t have to have them go in and set up in confined space and all kinds of stuff just to get a pressure reading. When it’s already electronic, you’re reading what’s going on live and without anybody having to go out to the valve.”

Using a mobile app, thorough data and photographs, Link2Valves can help operators engage in more successful service schedules and keep their assets up and running, even when social distancing and other considerations must be a priority. Instead of reacting to problems, service can be scheduled on a preventative or periodic basis.

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More